Stock market analysts have maintained ‘buy’ rating on Piramal Healthcare Ltd with an intraday target of Rs 421.

According to them, interested traders can purchase the stock with a strict stop loss of Rs 407.

If the stock markets remain on the positive path then the stock price will hit a target above Rs 425.

Shares of the company, on Wednesday (Dec 02), closed at Rs 414.50 on the Bombay Stock Exchange (BSE). The share price has seen a 52-week high of Rs 425 and a low of Rs 163.75 on BSE.

Current EPS & P/E ratio of the stock stood at 19.60 & 21.07 respectively.

The country's healthcare segment is likely to develop at 23% yearly to become a $77-billion industry by the next three years.

The report, which was jointly made by Assocham and Yes Bank, stated that India's healthcare division has developed at 9.3% yearly during 2000-09.

Healthcare services segment comprises companies, which are contingent upon and offer corollary services to hospitals, and is presently approximated at $1 billion.

According to the report, diagnostics would add $2.5 billion to the healthcare business by the next three years.

A growing number of public as well as private healthcare facilities are projected to push demand for the business, accounting for an added $6.7 billion by 2012.

With an escalating demand for reasonable quality healthcare, the penetration of health insurance is braced to go through an exponential growth to come out as a $3 billion industry by 2010.